#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=3. Discussion
1-1	0-2	3.	_	_	_	_
1-2	3-13	Discussion	abstract	new	_	_

#Text=The aim of this study was to elucidate the rMnSOD-dependent nSMase changes and their role in the protective-preventive effect from ionizing radiation in the brain .
2-1	14-17	The	abstract[2]	new[2]	coref	10-6[64_2]
2-2	18-21	aim	abstract[2]	new[2]	_	_
2-3	22-24	of	abstract[2]	new[2]	_	_
2-4	25-29	this	abstract[2]|abstract[3]	new[2]|new[3]	coref	10-1[63_3]
2-5	30-35	study	abstract[2]|abstract[3]	new[2]|new[3]	_	_
2-6	36-39	was	_	_	_	_
2-7	40-42	to	_	_	_	_
2-8	43-52	elucidate	_	_	_	_
2-9	53-56	the	abstract[6]|abstract[7]	new[6]|new[7]	ana	2-14[0_7]
2-10	57-73	rMnSOD-dependent	abstract|abstract[6]|abstract[7]	new|new[6]|new[7]	_	_
2-11	74-80	nSMase	abstract|abstract[6]|abstract[7]	new|new[6]|new[7]	coref	4-16
2-12	81-88	changes	abstract[6]|abstract[7]	new[6]|new[7]	_	_
2-13	89-92	and	abstract[7]	new[7]	_	_
2-14	93-98	their	abstract[7]|abstract|abstract[9]	new[7]|giv|new[9]	coref	8-5[48_9]
2-15	99-103	role	abstract[7]|abstract[9]	new[7]|new[9]	_	_
2-16	104-106	in	abstract[7]|abstract[9]	new[7]|new[9]	_	_
2-17	107-110	the	abstract[7]|abstract[9]|abstract[10]	new[7]|new[9]|new[10]	coref	7-1[42_10]
2-18	111-132	protective-preventive	abstract[7]|abstract[9]|abstract[10]	new[7]|new[9]|new[10]	_	_
2-19	133-139	effect	abstract[7]|abstract[9]|abstract[10]	new[7]|new[9]|new[10]	_	_
2-20	140-144	from	abstract[7]|abstract[9]|abstract[10]	new[7]|new[9]|new[10]	_	_
2-21	145-153	ionizing	abstract[7]|abstract[9]|abstract[10]|abstract[11]	new[7]|new[9]|new[10]|new[11]	coref	3-5[14_11]
2-22	154-163	radiation	abstract[7]|abstract[9]|abstract[10]|abstract[11]	new[7]|new[9]|new[10]|new[11]	_	_
2-23	164-166	in	abstract[7]|abstract[9]|abstract[10]	new[7]|new[9]|new[10]	_	_
2-24	167-170	the	abstract[7]|abstract[9]|abstract[10]|object[12]	new[7]|new[9]|new[10]|new[12]	coref	7-6[0_12]
2-25	171-176	brain	abstract[7]|abstract[9]|abstract[10]|object[12]	new[7]|new[9]|new[10]|new[12]	_	_
2-26	177-178	.	_	_	_	_

#Text=Mice were exposed to a set of minor γ radiation and neutrons and a spectrum of neutrons , simulating the radiation levels to which cosmonauts will be exposed during deep-space , long-term missions .
3-1	179-183	Mice	animal	new	_	_
3-2	184-188	were	_	_	_	_
3-3	189-196	exposed	_	_	_	_
3-4	197-199	to	_	_	_	_
3-5	200-201	a	abstract[14]	giv[14]	coref	3-21[0_14]
3-6	202-205	set	abstract[14]	giv[14]	_	_
3-7	206-208	of	abstract[14]	giv[14]	_	_
3-8	209-214	minor	abstract[14]	giv[14]	_	_
3-9	215-216	γ	abstract[14]	giv[14]	_	_
3-10	217-226	radiation	abstract[14]	giv[14]	_	_
3-11	227-230	and	_	_	_	_
3-12	231-239	neutrons	substance	new	coref	3-17
3-13	240-243	and	_	_	_	_
3-14	244-245	a	abstract[16]	new[16]	_	_
3-15	246-254	spectrum	abstract[16]	new[16]	_	_
3-16	255-257	of	abstract[16]	new[16]	_	_
3-17	258-266	neutrons	abstract[16]|substance	new[16]|giv	_	_
3-18	267-268	,	_	_	_	_
3-19	269-279	simulating	_	_	_	_
3-20	280-283	the	abstract[19]	new[19]	coref	14-9[100_19]
3-21	284-293	radiation	abstract|abstract[19]	giv|new[19]	coref	4-10
3-22	294-300	levels	abstract[19]	new[19]	_	_
3-23	301-303	to	abstract[19]	new[19]	_	_
3-24	304-309	which	abstract[19]	new[19]	_	_
3-25	310-320	cosmonauts	abstract[19]|person	new[19]|new	_	_
3-26	321-325	will	abstract[19]	new[19]	_	_
3-27	326-328	be	abstract[19]	new[19]	_	_
3-28	329-336	exposed	abstract[19]	new[19]	_	_
3-29	337-343	during	abstract[19]	new[19]	_	_
3-30	344-354	deep-space	abstract[19]|event[21]	new[19]|new[21]	_	_
3-31	355-356	,	abstract[19]|event[21]	new[19]|new[21]	_	_
3-32	357-366	long-term	abstract[19]|event[21]	new[19]|new[21]	_	_
3-33	367-375	missions	abstract[19]|event[21]	new[19]|new[21]	_	_
3-34	376-377	.	_	_	_	_

#Text=At the moment we do not know whether γ radiation only was unable to induce nSMase activation .
4-1	378-380	At	_	_	_	_
4-2	381-384	the	time[22]	new[22]	coref	18-2[136_22]
4-3	385-391	moment	time[22]	new[22]	_	_
4-4	392-394	we	person	acc	ana	5-1
4-5	395-397	do	_	_	_	_
4-6	398-401	not	_	_	_	_
4-7	402-406	know	_	_	_	_
4-8	407-414	whether	_	_	_	_
4-9	415-416	γ	abstract	new	_	_
4-10	417-426	radiation	abstract	giv	coref	7-4
4-11	427-431	only	_	_	_	_
4-12	432-435	was	_	_	_	_
4-13	436-442	unable	_	_	_	_
4-14	443-445	to	_	_	_	_
4-15	446-452	induce	_	_	_	_
4-16	453-459	nSMase	abstract|event[27]	giv|new[27]	coref	8-23
4-17	460-470	activation	event[27]	new[27]	_	_
4-18	471-472	.	_	_	_	_

#Text=We show that rMnSOD particles are capable to cross the blood-brain barrier and localize in the midbrain .
5-1	473-475	We	person	giv	ana	9-1
5-2	476-480	show	_	_	_	_
5-3	481-485	that	_	_	_	_
5-4	486-492	rMnSOD	abstract|object[30]	new|new[30]	coref	6-3
5-5	493-502	particles	object[30]	new[30]	_	_
5-6	503-506	are	_	_	_	_
5-7	507-514	capable	_	_	_	_
5-8	515-517	to	_	_	_	_
5-9	518-523	cross	_	_	_	_
5-10	524-527	the	object[32]	new[32]	_	_
5-11	528-539	blood-brain	abstract|object[32]	new|new[32]	_	_
5-12	540-547	barrier	object[32]	new[32]	_	_
5-13	548-551	and	_	_	_	_
5-14	552-560	localize	_	_	_	_
5-15	561-563	in	_	_	_	_
5-16	564-567	the	object[33]	new[33]	_	_
5-17	568-576	midbrain	object[33]	new[33]	_	_
5-18	577-578	.	_	_	_	_

#Text=Here , rMnSOD has the ability to limit radiation-induced damage , such as the loss of neuron number and the alteration of neurofilaments .
6-1	579-583	Here	_	_	_	_
6-2	584-585	,	_	_	_	_
6-3	586-592	rMnSOD	abstract	giv	coref	8-9
6-4	593-596	has	_	_	_	_
6-5	597-600	the	abstract[35]	new[35]	_	_
6-6	601-608	ability	abstract[35]	new[35]	_	_
6-7	609-611	to	abstract[35]	new[35]	_	_
6-8	612-617	limit	abstract[35]	new[35]	_	_
6-9	618-635	radiation-induced	abstract[35]|abstract[36]	new[35]|new[36]	coref	7-6[45_36]
6-10	636-642	damage	abstract[35]|abstract[36]	new[35]|new[36]	_	_
6-11	643-644	,	abstract[35]|abstract[36]	new[35]|new[36]	_	_
6-12	645-649	such	abstract[35]|abstract[36]	new[35]|new[36]	_	_
6-13	650-652	as	abstract[35]|abstract[36]	new[35]|new[36]	_	_
6-14	653-656	the	abstract[35]|abstract[36]|event[37]	new[35]|new[36]|new[37]	_	_
6-15	657-661	loss	abstract[35]|abstract[36]|event[37]	new[35]|new[36]|new[37]	_	_
6-16	662-664	of	abstract[35]|abstract[36]|event[37]	new[35]|new[36]|new[37]	_	_
6-17	665-671	neuron	abstract[35]|abstract[36]|event[37]|abstract|abstract[39]	new[35]|new[36]|new[37]|new|new[39]	_	_
6-18	672-678	number	abstract[35]|abstract[36]|event[37]|abstract[39]	new[35]|new[36]|new[37]|new[39]	_	_
6-19	679-682	and	abstract[35]|abstract[36]	new[35]|new[36]	_	_
6-20	683-686	the	abstract[35]|abstract[36]|event[40]	new[35]|new[36]|new[40]	_	_
6-21	687-697	alteration	abstract[35]|abstract[36]|event[40]	new[35]|new[36]|new[40]	_	_
6-22	698-700	of	abstract[35]|abstract[36]|event[40]	new[35]|new[36]|new[40]	_	_
6-23	701-715	neurofilaments	abstract[35]|abstract[36]|event[40]|abstract	new[35]|new[36]|new[40]|new	_	_
6-24	716-717	.	_	_	_	_

#Text=The effect of radiation on brain damage has previously been reported by other authors .
7-1	718-721	The	abstract[42]	giv[42]	coref	8-20[54_42]
7-2	722-728	effect	abstract[42]	giv[42]	_	_
7-3	729-731	of	abstract[42]	giv[42]	_	_
7-4	732-741	radiation	abstract[42]|abstract	giv[42]|giv	ana	8-20
7-5	742-744	on	abstract[42]	giv[42]	_	_
7-6	745-750	brain	abstract[42]|object|abstract[45]	giv[42]|giv|giv[45]	coref|coref	19-16|21-17[169_45]
7-7	751-757	damage	abstract[42]|abstract[45]	giv[42]|giv[45]	_	_
7-8	758-761	has	_	_	_	_
7-9	762-772	previously	_	_	_	_
7-10	773-777	been	_	_	_	_
7-11	778-786	reported	_	_	_	_
7-12	787-789	by	_	_	_	_
7-13	790-795	other	person[46]	new[46]	_	_
7-14	796-803	authors	person[46]	new[46]	_	_
7-15	804-805	.	_	_	_	_

#Text=Although many studies elucidated the radioprotective role of rMnSOD through antioxidant mechanisms in mitochondria , no data exist about its effect on nSMase .
8-1	806-814	Although	_	_	_	_
8-2	815-819	many	abstract[47]	new[47]	_	_
8-3	820-827	studies	abstract[47]	new[47]	_	_
8-4	828-838	elucidated	_	_	_	_
8-5	839-842	the	abstract[48]	giv[48]	coref	13-9[91_48]
8-6	843-858	radioprotective	abstract[48]	giv[48]	_	_
8-7	859-863	role	abstract[48]	giv[48]	_	_
8-8	864-866	of	abstract[48]	giv[48]	_	_
8-9	867-873	rMnSOD	abstract[48]|abstract	giv[48]|giv	coref	9-4
8-10	874-881	through	_	_	_	_
8-11	882-893	antioxidant	abstract[50]	new[50]	_	_
8-12	894-904	mechanisms	abstract[50]	new[50]	_	_
8-13	905-907	in	abstract[50]	new[50]	_	_
8-14	908-920	mitochondria	abstract[50]|animal	new[50]|new	_	_
8-15	921-922	,	_	_	_	_
8-16	923-925	no	abstract[52]	new[52]	coref	19-2[149_52]
8-17	926-930	data	abstract[52]	new[52]	_	_
8-18	931-936	exist	_	_	_	_
8-19	937-942	about	_	_	_	_
8-20	943-946	its	abstract|abstract[54]	giv|giv[54]	coref|coref	10-20[69_54]|12-12
8-21	947-953	effect	abstract[54]	giv[54]	_	_
8-22	954-956	on	abstract[54]	giv[54]	_	_
8-23	957-963	nSMase	abstract[54]|abstract	giv[54]|giv	coref	10-13
8-24	964-965	.	_	_	_	_

#Text=We show that rMnSOD stimulates nSMase gene and protein expression and enzymatic activity .
9-1	966-968	We	person	giv	ana	14-6
9-2	969-973	show	_	_	_	_
9-3	974-978	that	_	_	_	_
9-4	979-985	rMnSOD	abstract	giv	coref	10-18
9-5	986-996	stimulates	_	_	_	_
9-6	997-1003	nSMase	person|abstract[59]|abstract[61]	new|new[59]|new[61]	coref|coref|coref	11-11|11-11[78_59]|11-11[80_61]
9-7	1004-1008	gene	abstract[59]|abstract[61]	new[59]|new[61]	_	_
9-8	1009-1012	and	abstract[61]	new[61]	_	_
9-9	1013-1020	protein	substance|abstract[61]	new|new[61]	coref	11-14
9-10	1021-1031	expression	abstract[61]	new[61]	_	_
9-11	1032-1035	and	_	_	_	_
9-12	1036-1045	enzymatic	abstract[62]	new[62]	coref	17-30[135_62]
9-13	1046-1054	activity	abstract[62]	new[62]	_	_
9-14	1055-1056	.	_	_	_	_

#Text=The study was articulated with the aim of analyzing the response of nSMase in samples in which rMnSOD has a protective effect ( non-pretreated samples ) and in samples in which rMnSOD has a preventive effect ( pretreated samples ) .
10-1	1057-1060	The	abstract[63]	giv[63]	coref	11-4[75_63]
10-2	1061-1066	study	abstract[63]	giv[63]	_	_
10-3	1067-1070	was	_	_	_	_
10-4	1071-1082	articulated	_	_	_	_
10-5	1083-1087	with	_	_	_	_
10-6	1088-1091	the	abstract[64]	giv[64]	_	_
10-7	1092-1095	aim	abstract[64]	giv[64]	_	_
10-8	1096-1098	of	abstract[64]	giv[64]	_	_
10-9	1099-1108	analyzing	abstract[64]	giv[64]	_	_
10-10	1109-1112	the	abstract[64]|abstract[65]	giv[64]|new[65]	_	_
10-11	1113-1121	response	abstract[64]|abstract[65]	giv[64]|new[65]	_	_
10-12	1122-1124	of	abstract[64]|abstract[65]	giv[64]|new[65]	_	_
10-13	1125-1131	nSMase	abstract[64]|abstract[65]|abstract	giv[64]|new[65]|giv	coref	12-4
10-14	1132-1134	in	abstract[64]|abstract[65]	giv[64]|new[65]	_	_
10-15	1135-1142	samples	abstract[64]|abstract[65]|object[67]	giv[64]|new[65]|new[67]	appos	10-24[70_67]
10-16	1143-1145	in	abstract[64]|abstract[65]|object[67]	giv[64]|new[65]|new[67]	_	_
10-17	1146-1151	which	abstract[64]|abstract[65]|object[67]	giv[64]|new[65]|new[67]	_	_
10-18	1152-1158	rMnSOD	abstract[64]|abstract[65]|object[67]|abstract	giv[64]|new[65]|new[67]|giv	coref	10-32
10-19	1159-1162	has	abstract[64]|abstract[65]|object[67]	giv[64]|new[65]|new[67]	_	_
10-20	1163-1164	a	abstract[64]|abstract[65]|object[67]|abstract[69]	giv[64]|new[65]|new[67]|giv[69]	coref	10-34[72_69]
10-21	1165-1175	protective	abstract[64]|abstract[65]|object[67]|abstract[69]	giv[64]|new[65]|new[67]|giv[69]	_	_
10-22	1176-1182	effect	abstract[64]|abstract[65]|object[67]|abstract[69]	giv[64]|new[65]|new[67]|giv[69]	_	_
10-23	1183-1184	(	_	_	_	_
10-24	1185-1199	non-pretreated	object[70]	giv[70]	coref	11-2[73_70]
10-25	1200-1207	samples	object[70]	giv[70]	_	_
10-26	1208-1209	)	_	_	_	_
10-27	1210-1213	and	_	_	_	_
10-28	1214-1216	in	_	_	_	_
10-29	1217-1224	samples	_	_	_	_
10-30	1225-1227	in	_	_	_	_
10-31	1228-1233	which	_	_	_	_
10-32	1234-1240	rMnSOD	abstract	giv	coref	11-8
10-33	1241-1244	has	_	_	_	_
10-34	1245-1246	a	abstract[72]	giv[72]	coref	11-4[74_72]
10-35	1247-1257	preventive	abstract[72]	giv[72]	_	_
10-36	1258-1264	effect	abstract[72]	giv[72]	_	_
10-37	1265-1266	(	_	_	_	_
10-38	1267-1277	pretreated	_	_	_	_
10-39	1278-1285	samples	_	_	_	_
10-40	1286-1287	)	_	_	_	_
10-41	1288-1289	.	_	_	_	_

#Text=In samples for protective effect study , rMnSOD increases strongly nSMase gene and protein expression in irradiated samples in a dose-dependent manner .
11-1	1290-1292	In	_	_	_	_
11-2	1293-1300	samples	object[73]	giv[73]	coref	11-17[81_73]
11-3	1301-1304	for	object[73]	giv[73]	_	_
11-4	1305-1315	protective	object[73]|abstract[74]|abstract[75]	giv[73]|giv[74]|giv[75]	coref	17-4[124_74]
11-5	1316-1322	effect	object[73]|abstract[74]|abstract[75]	giv[73]|giv[74]|giv[75]	_	_
11-6	1323-1328	study	object[73]|abstract[75]	giv[73]|giv[75]	_	_
11-7	1329-1330	,	_	_	_	_
11-8	1331-1337	rMnSOD	abstract	giv	coref	14-21
11-9	1338-1347	increases	_	_	_	_
11-10	1348-1356	strongly	_	_	_	_
11-11	1357-1363	nSMase	person|abstract[78]|abstract[80]	giv|giv[78]|giv[80]	coref|coref	17-8[127_78]|17-8[129_80]
11-12	1364-1368	gene	abstract[78]|abstract[80]	giv[78]|giv[80]	_	_
11-13	1369-1372	and	abstract[80]	giv[80]	_	_
11-14	1373-1380	protein	substance|abstract[80]	giv|giv[80]	coref	17-11
11-15	1381-1391	expression	abstract[80]	giv[80]	_	_
11-16	1392-1394	in	abstract[80]	giv[80]	_	_
11-17	1395-1405	irradiated	abstract[80]|object[81]	giv[80]|giv[81]	coref	17-2[123_81]
11-18	1406-1413	samples	abstract[80]|object[81]	giv[80]|giv[81]	_	_
11-19	1414-1416	in	_	_	_	_
11-20	1417-1418	a	abstract[82]	new[82]	_	_
11-21	1419-1433	dose-dependent	abstract[82]	new[82]	_	_
11-22	1434-1440	manner	abstract[82]	new[82]	_	_
11-23	1441-1442	.	_	_	_	_

#Text=Small variations of nSMase enzyme activities are obtained only with high radiation doses .
12-1	1443-1448	Small	abstract[83]	new[83]	_	_
12-2	1449-1459	variations	abstract[83]	new[83]	_	_
12-3	1460-1462	of	abstract[83]	new[83]	_	_
12-4	1463-1469	nSMase	abstract[83]|abstract|abstract[86]	new[83]|giv|new[86]	coref	13-7
12-5	1470-1476	enzyme	abstract[83]|substance|abstract[86]	new[83]|new|new[86]	coref	15-26[112_0]
12-6	1477-1487	activities	abstract[83]|abstract[86]	new[83]|new[86]	_	_
12-7	1488-1491	are	_	_	_	_
12-8	1492-1500	obtained	_	_	_	_
12-9	1501-1505	only	_	_	_	_
12-10	1506-1510	with	_	_	_	_
12-11	1511-1515	high	abstract[88]	new[88]	_	_
12-12	1516-1525	radiation	abstract|abstract[88]	giv|new[88]	coref	14-10
12-13	1526-1531	doses	abstract[88]	new[88]	_	_
12-14	1532-1533	.	_	_	_	_

#Text=This observation is relevant , as nSMase plays a crucial role in the regulation of ROS generation and in the maintenance of homeostasis between proapoptotic and prosurvival signals .
13-1	1534-1538	This	abstract[89]	new[89]	_	_
13-2	1539-1550	observation	abstract[89]	new[89]	_	_
13-3	1551-1553	is	_	_	_	_
13-4	1554-1562	relevant	_	_	_	_
13-5	1563-1564	,	_	_	_	_
13-6	1565-1567	as	_	_	_	_
13-7	1568-1574	nSMase	abstract	giv	coref	14-14
13-8	1575-1580	plays	_	_	_	_
13-9	1581-1582	a	abstract[91]	giv[91]	_	_
13-10	1583-1590	crucial	abstract[91]	giv[91]	_	_
13-11	1591-1595	role	abstract[91]	giv[91]	_	_
13-12	1596-1598	in	abstract[91]	giv[91]	_	_
13-13	1599-1602	the	abstract[91]|abstract[92]	giv[91]|new[92]	_	_
13-14	1603-1613	regulation	abstract[91]|abstract[92]	giv[91]|new[92]	_	_
13-15	1614-1616	of	abstract[91]|abstract[92]	giv[91]|new[92]	_	_
13-16	1617-1620	ROS	abstract[91]|abstract[92]|abstract|abstract[94]	giv[91]|new[92]|new|new[94]	coref	19-25
13-17	1621-1631	generation	abstract[91]|abstract[92]|abstract[94]	giv[91]|new[92]|new[94]	_	_
13-18	1632-1635	and	_	_	_	_
13-19	1636-1638	in	_	_	_	_
13-20	1639-1642	the	abstract[95]	new[95]	_	_
13-21	1643-1654	maintenance	abstract[95]	new[95]	_	_
13-22	1655-1657	of	abstract[95]	new[95]	_	_
13-23	1658-1669	homeostasis	abstract[95]|abstract[96]	new[95]|new[96]	_	_
13-24	1670-1677	between	abstract[95]|abstract[96]	new[95]|new[96]	_	_
13-25	1678-1690	proapoptotic	abstract[95]|abstract[96]|abstract[97]	new[95]|new[96]|new[97]	_	_
13-26	1691-1694	and	abstract[95]|abstract[96]|abstract[97]	new[95]|new[96]|new[97]	_	_
13-27	1695-1706	prosurvival	abstract[95]|abstract[96]|abstract[97]	new[95]|new[96]|new[97]	_	_
13-28	1707-1714	signals	abstract[95]|abstract[96]|abstract[97]	new[95]|new[96]|new[97]	_	_
13-29	1715-1716	.	_	_	_	_

#Text=In line with this , we show that highest radiation levels induce significant nSMase responses only in the presence of rMnSOD .
14-1	1717-1719	In	_	_	_	_
14-2	1720-1724	line	_	_	_	_
14-3	1725-1729	with	_	_	_	_
14-4	1730-1734	this	_	_	_	_
14-5	1735-1736	,	_	_	_	_
14-6	1737-1739	we	person	giv	ana	15-17
14-7	1740-1744	show	_	_	_	_
14-8	1745-1749	that	_	_	_	_
14-9	1750-1757	highest	abstract[100]	giv[100]	coref	18-9[139_100]
14-10	1758-1767	radiation	abstract|abstract[100]	giv|giv[100]	coref	19-20
14-11	1768-1774	levels	abstract[100]	giv[100]	_	_
14-12	1775-1781	induce	_	_	_	_
14-13	1782-1793	significant	event[102]	new[102]	_	_
14-14	1794-1800	nSMase	abstract|event[102]	giv|new[102]	coref	15-7
14-15	1801-1810	responses	event[102]	new[102]	_	_
14-16	1811-1815	only	_	_	_	_
14-17	1816-1818	in	_	_	_	_
14-18	1819-1822	the	abstract[103]	new[103]	_	_
14-19	1823-1831	presence	abstract[103]	new[103]	_	_
14-20	1832-1834	of	abstract[103]	new[103]	_	_
14-21	1835-1841	rMnSOD	abstract[103]|abstract	new[103]|giv	coref	15-15
14-22	1842-1843	.	_	_	_	_

#Text=Although the present results indicate that nSMase may be required for the action of rMnSOD , we cannot prove the direct action of rMnSOD on this enzyme .
15-1	1844-1852	Although	_	_	_	_
15-2	1853-1856	the	abstract[105]	new[105]	_	_
15-3	1857-1864	present	abstract[105]	new[105]	_	_
15-4	1865-1872	results	abstract[105]	new[105]	_	_
15-5	1873-1881	indicate	_	_	_	_
15-6	1882-1886	that	_	_	_	_
15-7	1887-1893	nSMase	abstract	giv	coref	17-8
15-8	1894-1897	may	_	_	_	_
15-9	1898-1900	be	_	_	_	_
15-10	1901-1909	required	_	_	_	_
15-11	1910-1913	for	_	_	_	_
15-12	1914-1917	the	event[107]	new[107]	_	_
15-13	1918-1924	action	event[107]	new[107]	_	_
15-14	1925-1927	of	event[107]	new[107]	_	_
15-15	1928-1934	rMnSOD	event[107]|abstract	new[107]|giv	coref	15-24
15-16	1935-1936	,	_	_	_	_
15-17	1937-1939	we	person	giv	ana	16-2
15-18	1940-1946	cannot	_	_	_	_
15-19	1947-1952	prove	_	_	_	_
15-20	1953-1956	the	abstract[110]	new[110]	ana	16-5[0_110]
15-21	1957-1963	direct	abstract[110]	new[110]	_	_
15-22	1964-1970	action	abstract[110]	new[110]	_	_
15-23	1971-1973	of	abstract[110]	new[110]	_	_
15-24	1974-1980	rMnSOD	abstract[110]|abstract	new[110]|giv	coref	16-17
15-25	1981-1983	on	abstract[110]	new[110]	_	_
15-26	1984-1988	this	abstract[110]|substance[112]	new[110]|giv[112]	coref	17-31[0_112]
15-27	1989-1995	enzyme	abstract[110]|substance[112]	new[110]|giv[112]	_	_
15-28	1996-1997	.	_	_	_	_

#Text=To our knowledge , this is the first study indicating SMase as a potential effector of rMnSOD during its protection action .
16-1	1998-2000	To	_	_	_	_
16-2	2001-2004	our	person|abstract[114]	giv|new[114]	ana	18-4
16-3	2005-2014	knowledge	abstract[114]	new[114]	_	_
16-4	2015-2016	,	_	_	_	_
16-5	2017-2021	this	abstract	giv	coref	16-7[116_0]
16-6	2022-2024	is	_	_	_	_
16-7	2025-2028	the	abstract[116]	giv[116]	coref	16-19[122_116]
16-8	2029-2034	first	abstract[116]	giv[116]	_	_
16-9	2035-2040	study	abstract[116]	giv[116]	_	_
16-10	2041-2051	indicating	abstract[116]	giv[116]	_	_
16-11	2052-2057	SMase	abstract[116]|abstract	giv[116]|new	_	_
16-12	2058-2060	as	abstract[116]	giv[116]	_	_
16-13	2061-2062	a	abstract[116]|abstract[118]	giv[116]|new[118]	_	_
16-14	2063-2072	potential	abstract[116]|abstract[118]	giv[116]|new[118]	_	_
16-15	2073-2081	effector	abstract[116]|abstract[118]	giv[116]|new[118]	_	_
16-16	2082-2084	of	abstract[116]|abstract[118]	giv[116]|new[118]	_	_
16-17	2085-2091	rMnSOD	abstract[116]|abstract[118]|abstract	giv[116]|new[118]|giv	ana	16-19
16-18	2092-2098	during	abstract[116]|abstract[118]	giv[116]|new[118]	_	_
16-19	2099-2102	its	abstract[116]|abstract[118]|abstract|abstract[122]	giv[116]|new[118]|giv|giv[122]	coref|coref	17-4[125_122]|17-26
16-20	2103-2113	protection	abstract[116]|abstract[118]|abstract|abstract[122]	giv[116]|new[118]|new|giv[122]	_	_
16-21	2114-2120	action	abstract[116]|abstract[118]|abstract[122]	giv[116]|new[118]|giv[122]	_	_
16-22	2121-2122	.	_	_	_	_

#Text=In samples for preventive effect study , nSMase gene and protein expression is reduced in comparison with the samples in which the protective effect of rMnSOD is studied but the enzyme activity is much higher .
17-1	2123-2125	In	_	_	_	_
17-2	2126-2133	samples	object[123]	giv[123]	coref	17-18[131_123]
17-3	2134-2137	for	object[123]	giv[123]	_	_
17-4	2138-2148	preventive	object[123]|abstract[124]|abstract[125]	giv[123]|giv[124]|giv[125]	_	_
17-5	2149-2155	effect	object[123]|abstract[124]|abstract[125]	giv[123]|giv[124]|giv[125]	_	_
17-6	2156-2161	study	object[123]|abstract[125]	giv[123]|giv[125]	_	_
17-7	2162-2163	,	_	_	_	_
17-8	2164-2170	nSMase	abstract|abstract[127]|abstract[129]	giv|giv[127]|giv[129]	coref|coref|coref	18-9|18-36[0_127]|18-35[148_129]
17-9	2171-2175	gene	abstract[127]|abstract[129]	giv[127]|giv[129]	_	_
17-10	2176-2179	and	abstract[129]	giv[129]	_	_
17-11	2180-2187	protein	substance|abstract[129]	giv|giv[129]	_	_
17-12	2188-2198	expression	abstract[129]	giv[129]	_	_
17-13	2199-2201	is	_	_	_	_
17-14	2202-2209	reduced	_	_	_	_
17-15	2210-2212	in	_	_	_	_
17-16	2213-2223	comparison	abstract[130]	new[130]	_	_
17-17	2224-2228	with	abstract[130]	new[130]	_	_
17-18	2229-2232	the	abstract[130]|object[131]	new[130]|giv[131]	_	_
17-19	2233-2240	samples	abstract[130]|object[131]	new[130]|giv[131]	_	_
17-20	2241-2243	in	abstract[130]|object[131]	new[130]|giv[131]	_	_
17-21	2244-2249	which	abstract[130]|object[131]	new[130]|giv[131]	_	_
17-22	2250-2253	the	abstract[130]|object[131]|abstract[132]	new[130]|giv[131]|new[132]	_	_
17-23	2254-2264	protective	abstract[130]|object[131]|abstract[132]	new[130]|giv[131]|new[132]	_	_
17-24	2265-2271	effect	abstract[130]|object[131]|abstract[132]	new[130]|giv[131]|new[132]	_	_
17-25	2272-2274	of	abstract[130]|object[131]|abstract[132]	new[130]|giv[131]|new[132]	_	_
17-26	2275-2281	rMnSOD	abstract[130]|object[131]|abstract[132]|abstract	new[130]|giv[131]|new[132]|giv	_	_
17-27	2282-2284	is	abstract[130]|object[131]	new[130]|giv[131]	_	_
17-28	2285-2292	studied	abstract[130]|object[131]	new[130]|giv[131]	_	_
17-29	2293-2296	but	abstract[130]|object[131]	new[130]|giv[131]	_	_
17-30	2297-2300	the	abstract[130]|object[131]|abstract[135]	new[130]|giv[131]|giv[135]	_	_
17-31	2301-2307	enzyme	abstract[130]|object[131]|substance|abstract[135]	new[130]|giv[131]|giv|giv[135]	_	_
17-32	2308-2316	activity	abstract[130]|object[131]|abstract[135]	new[130]|giv[131]|giv[135]	_	_
17-33	2317-2319	is	abstract[130]|object[131]	new[130]|giv[131]	_	_
17-34	2320-2324	much	abstract[130]|object[131]	new[130]|giv[131]	_	_
17-35	2325-2331	higher	abstract[130]|object[131]	new[130]|giv[131]	_	_
17-36	2332-2333	.	_	_	_	_

#Text=At this moment we can only speculate why nSMase levels are reduced with pretreatment , a possible explanation being that an extended treatment time could stimulate different metabolic patterns , leading to inhibition of nSMase gene expression .
18-1	2334-2336	At	_	_	_	_
18-2	2337-2341	this	time[136]	giv[136]	_	_
18-3	2342-2348	moment	time[136]	giv[136]	_	_
18-4	2349-2351	we	person	giv	ana	19-6
18-5	2352-2355	can	_	_	_	_
18-6	2356-2360	only	_	_	_	_
18-7	2361-2370	speculate	_	_	_	_
18-8	2371-2374	why	_	_	_	_
18-9	2375-2381	nSMase	abstract|abstract[139]	giv|giv[139]	coref|coref	18-35|19-35[161_139]
18-10	2382-2388	levels	abstract[139]	giv[139]	_	_
18-11	2389-2392	are	_	_	_	_
18-12	2393-2400	reduced	_	_	_	_
18-13	2401-2405	with	_	_	_	_
18-14	2406-2418	pretreatment	event	new	_	_
18-15	2419-2420	,	_	_	_	_
18-16	2421-2422	a	abstract[141]	new[141]	_	_
18-17	2423-2431	possible	abstract[141]	new[141]	_	_
18-18	2432-2443	explanation	abstract[141]	new[141]	_	_
18-19	2444-2449	being	_	_	_	_
18-20	2450-2454	that	_	_	_	_
18-21	2455-2457	an	time[143]	new[143]	_	_
18-22	2458-2466	extended	time[143]	new[143]	_	_
18-23	2467-2476	treatment	abstract|time[143]	new|new[143]	_	_
18-24	2477-2481	time	time[143]	new[143]	_	_
18-25	2482-2487	could	_	_	_	_
18-26	2488-2497	stimulate	_	_	_	_
18-27	2498-2507	different	abstract[144]	new[144]	_	_
18-28	2508-2517	metabolic	abstract[144]	new[144]	_	_
18-29	2518-2526	patterns	abstract[144]	new[144]	_	_
18-30	2527-2528	,	_	_	_	_
18-31	2529-2536	leading	_	_	_	_
18-32	2537-2539	to	_	_	_	_
18-33	2540-2550	inhibition	event[145]	new[145]	_	_
18-34	2551-2553	of	event[145]	new[145]	_	_
18-35	2554-2560	nSMase	event[145]|abstract|abstract[148]	new[145]|giv|giv[148]	ana|coref	19-9[0_148]|19-30
18-36	2561-2565	gene	event[145]|abstract|abstract[148]	new[145]|giv|giv[148]	_	_
18-37	2566-2576	expression	event[145]|abstract[148]	new[145]|giv[148]	_	_
18-38	2577-2578	.	_	_	_	_

#Text=Merging already published data with our findings , it is possible to suggest that in brain tissues exposed to radiation , significant amounts of ROS are generated , stimulating nSMase production to significantly increase MnSOD levels .
19-1	2579-2586	Merging	_	_	_	_
19-2	2587-2594	already	abstract[149]	giv[149]	_	_
19-3	2595-2604	published	abstract[149]	giv[149]	_	_
19-4	2605-2609	data	abstract[149]	giv[149]	_	_
19-5	2610-2614	with	_	_	_	_
19-6	2615-2618	our	person|abstract[151]	giv|new[151]	_	_
19-7	2619-2627	findings	abstract[151]	new[151]	_	_
19-8	2628-2629	,	_	_	_	_
19-9	2630-2632	it	abstract	giv	_	_
19-10	2633-2635	is	_	_	_	_
19-11	2636-2644	possible	_	_	_	_
19-12	2645-2647	to	_	_	_	_
19-13	2648-2655	suggest	_	_	_	_
19-14	2656-2660	that	_	_	_	_
19-15	2661-2663	in	_	_	_	_
19-16	2664-2669	brain	object|object[154]	giv|new[154]	_	_
19-17	2670-2677	tissues	object[154]	new[154]	_	_
19-18	2678-2685	exposed	object[154]	new[154]	_	_
19-19	2686-2688	to	object[154]	new[154]	_	_
19-20	2689-2698	radiation	object[154]|abstract	new[154]|giv	_	_
19-21	2699-2700	,	_	_	_	_
19-22	2701-2712	significant	substance[156]	new[156]	_	_
19-23	2713-2720	amounts	substance[156]	new[156]	_	_
19-24	2721-2723	of	substance[156]	new[156]	_	_
19-25	2724-2727	ROS	substance[156]|abstract	new[156]|giv	coref	21-5
19-26	2728-2731	are	_	_	_	_
19-27	2732-2741	generated	_	_	_	_
19-28	2742-2743	,	_	_	_	_
19-29	2744-2755	stimulating	_	_	_	_
19-30	2756-2762	nSMase	abstract|abstract[159]	giv|new[159]	ana|coref	20-1[0_159]|20-6
19-31	2763-2773	production	abstract[159]	new[159]	_	_
19-32	2774-2776	to	_	_	_	_
19-33	2777-2790	significantly	_	_	_	_
19-34	2791-2799	increase	_	_	_	_
19-35	2800-2805	MnSOD	abstract|abstract[161]	new|giv[161]	coref	21-5[166_161]
19-36	2806-2812	levels	abstract[161]	giv[161]	_	_
19-37	2813-2814	.	_	_	_	_

#Text=This may in turn stimulate nSMase .
20-1	2815-2819	This	abstract	giv	_	_
20-2	2820-2823	may	_	_	_	_
20-3	2824-2826	in	_	_	_	_
20-4	2827-2831	turn	_	_	_	_
20-5	2832-2841	stimulate	_	_	_	_
20-6	2842-2848	nSMase	abstract	giv	coref	22-9
20-7	2849-2850	.	_	_	_	_

#Text=At this point , ROS levels may be reduced , with the end result of limiting the damage .
21-1	2851-2853	At	_	_	_	_
21-2	2854-2858	this	time[164]	new[164]	_	_
21-3	2859-2864	point	time[164]	new[164]	_	_
21-4	2865-2866	,	_	_	_	_
21-5	2867-2870	ROS	abstract|abstract[166]	giv|giv[166]	_	_
21-6	2871-2877	levels	abstract[166]	giv[166]	_	_
21-7	2878-2881	may	_	_	_	_
21-8	2882-2884	be	_	_	_	_
21-9	2885-2892	reduced	_	_	_	_
21-10	2893-2894	,	_	_	_	_
21-11	2895-2899	with	_	_	_	_
21-12	2900-2903	the	abstract[168]	new[168]	_	_
21-13	2904-2907	end	event|abstract[168]	new|new[168]	_	_
21-14	2908-2914	result	abstract[168]	new[168]	_	_
21-15	2915-2917	of	abstract[168]	new[168]	_	_
21-16	2918-2926	limiting	abstract[168]	new[168]	_	_
21-17	2927-2930	the	abstract[168]|abstract[169]	new[168]|giv[169]	_	_
21-18	2931-2937	damage	abstract[168]|abstract[169]	new[168]|giv[169]	_	_
21-19	2938-2939	.	_	_	_	_

#Text=In the above described series of events , nSMase may play predominant roles .
22-1	2940-2942	In	_	_	_	_
22-2	2943-2946	the	abstract[170]	new[170]	_	_
22-3	2947-2952	above	abstract[170]	new[170]	_	_
22-4	2953-2962	described	abstract[170]	new[170]	_	_
22-5	2963-2969	series	abstract[170]	new[170]	_	_
22-6	2970-2972	of	abstract[170]	new[170]	_	_
22-7	2973-2979	events	abstract[170]|event	new[170]|new	_	_
22-8	2980-2981	,	_	_	_	_
22-9	2982-2988	nSMase	abstract	giv	_	_
22-10	2989-2992	may	_	_	_	_
22-11	2993-2997	play	_	_	_	_
22-12	2998-3009	predominant	abstract[173]	new[173]	_	_
22-13	3010-3015	roles	abstract[173]	new[173]	_	_
22-14	3016-3017	.	_	_	_	_
